Ketamine for the treatment of major depression: a systematic review and meta-analysis
eClinicalMedicine, 2023
A meta-analysis of 49 randomized controlled trials in over 3,000 patients found both racemic ketamine and esketamine produced meaningful reductions in depression severity.
View on PubMed →

